University of Pennsylvania-Abramson Cancer Center — Philadelphia, Pennsylvania

University of Pennsylvania-Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pennsylvania-Abramson Cancer Center has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Triple Negative Breast Cancer, Residual Cancer.

Sponsors: Dana-Farber Cancer Institute, Taiho Oncology, Inc., Ana C Garrido-Castro, MD.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania-Abramson Cancer Center?

University of Pennsylvania-Abramson Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania-Abramson Cancer Center conducted?

University of Pennsylvania-Abramson Cancer Center has 6 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Triple Negative Breast Cancer, Residual Cancer.

Is University of Pennsylvania-Abramson Cancer Center accredited by Crixeo Health?

Yes — University of Pennsylvania-Abramson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Pennsylvania-Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.